Beauty Health Co (SKIN) - Dilution Analysis

10-Q filing | 131.4M shares outstanding

10-K filing | 126.4M shares outstanding

10-Q filing | 126.9M shares outstanding

10-Q filing | 125.1M shares outstanding

10-K filing | 123.8M shares outstanding

10-Q filing | 124.1M shares outstanding

10-Q filing | 123.7M shares outstanding

10-Q filing | 123.1M shares outstanding

10-K filing | 131.7M shares outstanding

10-Q filing | 132.9M shares outstanding

10-Q filing | 132.7M shares outstanding

10-Q filing | 132.4M shares outstanding

8-K filing: The Beauty Health Company acquired all outstanding shares of Esthetic Medical Inc. from Dr. Lawrence Groop in exchange for cash and 109,625 shares of Class A common stock of the Company.

10-K filing | 132.5M shares outstanding

POS AM filing: The Beauty Health Company is offering up to 68,433,360 shares of Class A Common Stock, 6,970,000 warrants to purchase shares of Class A Common Stock and 6,970,000 shares of Class A Common Stock underlying warrants by Registered Holders.

10-Q filing | 150.8M shares outstanding

8-K filing: The Beauty Health Company entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association to repurchase up to $100.0 million of the Company's Class A common stock, with an initial delivery of approximately 7,692,308 shares expected on September 29, 2022. ($100.0M proceeds)

S-3 filing: The Beauty Health Company is offering up to 65,618 shares of Class A Common Stock by registered holders.

10-Q filing | 150.7M shares outstanding

10-Q filing | 150.6M shares outstanding

POS AM filing: This prospectus relates to the resale of Class A common stock and warrants by selling stockholders, as well as the issuance of shares upon exercise of outstanding warrants.

10-K filing | 150.6M shares outstanding

10-Q filing | 149.6M shares outstanding

8-K filing: The Beauty Health Company announced that approximately 6.86 million redeemable warrants had been exercised as of October 18, 2021, and there are approximately 8.47 million redeemable warrants that have not been exercised and will be redeemed on November 3, 2021, at a price of $0.10 per warrant if not exercised before then.

8-K filing: The Beauty Health Company issued $750,000,000 principal amount of 1.25% Convertible Senior Notes due 2026 and may issue up to 31,289,100 shares of common stock upon conversion of the Notes.

10-Q filing | 133.4M shares outstanding

S-1 filing: This S-1 filing relates to the resale of Class A common stock and warrants by selling stockholders, as well as the issuance of Class A common stock upon the exercise of outstanding warrants.

10-Q filing | 125.9M shares outstanding

10-K filing | 46.0M shares outstanding

8-K filing: Vesper Healthcare Acquisition Corp. entered into a merger agreement with HydraFacial, and simultaneously entered into subscription agreements for a private placement of 35,000,000 shares of Company Common Stock at $10.00 per share. ($350.0M proceeds)

10-Q filing | 46.0M shares outstanding

8-K filing: Vesper Healthcare Acquisition Corp. completed its IPO of 46,000,000 units at $10.00 per unit, generating gross proceeds of $460,000,000, and simultaneously completed the private sale of 9,333,333 warrants to the Sponsor at $1.50 per warrant, generating gross proceeds of $14,000,000. ($474.0M proceeds)

S-1/A filing: Initial public offering of 40,000,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one-third of one redeemable warrant.

S-1 filing: Vesper Healthcare Acquisition Corp. is offering 40,000,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one-third of one redeemable warrant in an initial public offering.